药物发现信息学市场份额、规模、趋势、行业分析报告，按工作流程（发现信息学、开发信息学）；按模式（外包、内部）；按服务（序列分析平台、分子建模、对接、临床试验数据管理等）；按地区划分；2021-2028年细分市场预测必威开户注册

报告摘要

The global drug discovery informatics market was valued at USD 2.42 billion in 2020 and is expected to grow at a CAGR of 11.4% during the forecast period. Key factors responsible for the market growth include advances in computing capabilities with rising adoption of AI and machine learning, increase in adoption of in-silico tools modeling tools, a huge volume of drug discovery data, and burgeoning demand for the new medicine or drugs.

了解有关此报告的更多信息:request for sample pages

此外，新数据发现平台的引入将加剧市场竞争。在这方面，Certara于2021年1月推出了新版本的Simcyp生理药代动力学（PBPK）模拟平台，用于评估和分析哺乳期、妊娠期和其他医疗条件下的药物作用。

Furthermore, it helps users in deciding critical decisions with regard to drug safety and efficacy profile. Companies in the marketplace are continuously adopting computing capabilities dedicated to informatics to shorten long drug discovery process time.

2020年12月，Curve Therapeutics实施了CDD保险库平台，以管理其基因编码的微周期平台。该平台适用于跨平台的无缝应用程序生物技术, drug discovery stakeholders, pharma, and academic institutions to share real-time data for collaborative discoveries.

Drug Discovery Informatics Market Report Scope

The market is primarily segmented on the basis of workflow, mode, services, and region.

按工作流	按模式	按服务必威开户注册	按地区
发现信息学 鉴定、验证和分析开发信息学 潜在顾客开发 发展信息学 Lead Optimization FHD准备 IA相 Phase IB/2	Outsourced 内部	Sequence Analysis Platforms 分子模拟 Docking Clinical Trial Data Management Others	北美（美国、加拿大） 欧洲（法国、德国、英国、意大利、西班牙、荷兰、奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西、墨西哥、阿根廷） MEA（沙特阿拉伯、阿联酋、以色列、南非）

了解有关此报告的更多信息:request for sample pages

Insight by Workflow

在2020年，发现信息学市场占有最大的收入份额。这一高份额主要是由于对精确药物开发的强烈关注。它涉及基于其基因和分子特征的特定患者护理。PerkinElmer，Inc.等公司是此类药物发现信息学解决方案的重要供应商，通过利用市场上快速药物发现信息学解决方案的分析手段。

此外，世界各地的一些政府正在迅速采用生物信息学来快速发现药物分子。在这方面，印度政府在2020年7月推出了药物发现Hackathon（DDH）。这是一个培训模块，以促进发现有效的分子对COVID-19与巨大的应用在药物发现工具的识别，设计和验证潜在的先导化合物。

药物开发市场部分预计将见证一个有利可图的增长率在研究期间。这主要是由于制药公司的候选药物数量增加。这些工具广泛用于执行临床试验设计所需的任务，以提高试验性能和分析速度。

按模式查看

In 2020, the outsourced informatics market segment accounted for the largest share and is likely to register a steady market growth rate over the study period. This high share is attributed to rising partnerships between pharma companies and the contract research organizations involved in the development of new drug entities which are subsequently used by drug manufacturers for applying to the US. regulatory agency.

制药和生物技术公司与在药物信息学方面具有重要专业知识的首席风险官合作有几个好处。主办公司和首席风险官之间使用的共享信息平台有助于监测研究进展。这也有助于公司节约成本，提高生产率，从而预计将提供大量有利可图的市场机会。

The in-house market segment is projected to register a lucrative growth rate over the study period. This is due to the rising adoption of informatics solutions by large established pharmaceutical players across the globe. It offers, numerous advantages, such as direct access to information, lengthy data compilation.

Geographic Overview

地理上,全球药物发现备用ics market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). North America market is the largest revenue contributor followed by Europe and the Asia Pacific market.

In 2020, the North America drug discovery informatics market accounted for over 35.0% of the global market. This high share is attributed to few notable factors such as an increase in the incidence of infectious diseases, the presence of major market players, and the increasing need for advanced drug discovery tools to expedite the drug approval timeline.

Moreover, companies in the region are focusing on collaborations, and joint ventures to boost the region’s market growth. In this direction, in December 2020, Atomwise collaborated with vAirus, OrganAi, and A2i Therapeutics with several programs falling in the category of oncology, neuroscience, immunology, and clotting disorders.

竞争洞察力

在市场上运营的著名公司有Certara、Infosys Ltd、Albany Molecular Research Inc、Charles River Laboratories、Boehringer Ingelheim、Collaborative Drug Discovery、Jubilant Biosys、Selvita、Novo Information、Eurofins Discovery Products、ChemAxon Ltd、Oracle、Accenture、Agilent Technologies，Inc.和Illumina，Inc。